Triple T Foundation does not provide medical advice or recommendations. Please consult your medical team for specific information for your individual situation.
Tamoxifen is a hormone therapy. This medication is classified as an "anti-estrogen".
Toremifene is a hormone therapy. It is classified as an estrogen receptor antagonist or "anti-estrogen".
Fulvestrant is a hormone therapy. It fights cancer as an "estrogen receptor downregulator."
Femara® is the trade name for the generic drug letrozole. In some cases, health care professionals may use the trade name Femara® ® when referring to the generic drug name letrozole.
Anastrozole is the generic name for the trade name drug Arimidex®. In some cases, health care professionals may use the trade name Arimidex® when referring to the generic drug name Anastrozole.
Exemestane is the generic name for the trade name drug Aromasin®. In some cases, health care professionals may use the trade name Aromasin® when referring to the generic drug name exemestane.
Goserelin is a hormone therapy. It is classified as an "LHRH agonist."
Lupron is a hormone therapy. It is classified as an "LHRH agonist." (